Karyopharm Therapeutics | KPTI - 무역 채권자





무역 채권자 변화 날짜
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.68B 439M 2026-03
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
GlaxoSmithKline GBP 14.34B 7M 2026-06
Incyte USD 1.39B 1.16B 2026-06
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
MacroGenics USD 3.44M 845K 2026-06
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.58B 75M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Takeda JPY 446.78B 44.56B 2026-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
TG Therapeutics USD 213.69M 64.85M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Xencor USD 12.65M 4.73M 2026-06